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Abstract
Aims: To report research terminology and definitions for describing healthy bladder function
among women and girls.
Methods: The Prevention of Lower Urinary tract Symptoms (PLUS) Consortium developed
research terminology and definitions for elements of healthy bladder function based on existing
understanding of storage and emptying functions of the bladder and accepted definitions of lower
urinary tract symptoms (LUTS). The novel concept of a bladder “bioregulatory” function was also
proposed. Elements of bladder function corresponding to bladder health (BH) and LUTS were
developed and refined using an iterative process. A comprehensive reference table structured by
bladder function (Storage, Emptying, Bioregulatory) and elements of each function was created to
document proposed research terminology and definitions.

Author Manuscript

Results: The BH research definitions for each bladder function are: 1) Storage: The ability to
hold urine for a reasonable duration of time and sense bladder fullness without fear of or concern
about urgency, discomfort or leakage; 2) Emptying: The ability to empty the bladder completely in
a timely, efficient, effortless, comfortable manner; and 3) Bioregulatory: The bladder barrier
protects the individual/host from pathogens, chemicals, and malignancy. Research definitions for 7
Storage, 7 Emptying, and 3 Bioregulatory elements of function are presented. Novel LUTS
research definitions were developed when gaps in existing definitions were identified or nonclinical language was desired.
Neurourol Urodyn. Author manuscript; available in PMC 2020 June 01.
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Conclusions: PLUS BH definitions reflect a transdisciplinary approach to standardizing
research definitions for elements of bladder function from a perspective of health rather than
dysfunction and provide a framework for studying BH in clinical practice, public health promotion
and LUTS prevention.

Introduction

Author Manuscript

Bladder function has been defined primarily through the presence or absence of lower
urinary tract symptoms (LUTS) rather than corresponding indices of health. The
International Continence Society (ICS) reports on LUTS, the International Urogynecologic
Association (IUGA) and ICS joint report on female pelvic floor dysfunction, and the
International Children’ Continence Society (ICCS) report provide excellent resources for
LUTS and pelvic floor dysfunction terminology for women of all ages.1–7 However, current
understanding of bladder function and terminology focus on definitions of bothersome
LUTS rather than normal bladder function.1–7 Furthermore, current validated questionnaires
related to bladder function focus primarily on bothersome symptoms of LUTS pathology
(e.g. incontinence) rather than the full spectrum of bladder function. A narrow focus on
single aspects of dysfunction, rather than a holistic focus on the spectrum of health to
dysfunction, has led to challenges with measurement and interpretation for most studies
related to LUTS. For example, assuming that the absence of urinary incontinence is an
indicator of bladder health may not be accurate because other bladder pathologies (e.g.
infections or retention) may exist. In addition, the absence of single or multiple bladder
pathologies does not necessarily imply optimal bladder health. We have learned from other
areas of medicine that the lack of clinically manifest disease does not always equate to
health.8

Author Manuscript
Author Manuscript

Promotion of optimal bladder function and prevention of LUTS is particularly important for
girls and women. Women are at higher risk than men are for specific LUTS such as urinary
incontinence and urinary tract infections due to the anatomy and physiology of the female
urogenital system, women’s hormonal milieu, pregnancy and childbirth, and in many
contexts, gendered inequities.9–12 Moreover, LUTS tend to begin earlier in the life course
for women than for men.10,13 To date, neither bladder health nor normal bladder function(s)
have been adequately researched in women or girls. We posit that clear definitions of both
health and disease are critical to conducting research that can inform understanding and
promotion of optimal bladder function. This premise is consistent with the discipline and
tenets of prevention science, which involves the systematic study of potential precursors to
both human dysfunction and health.14,15 To study and promote optimal bladder function, an
agreed upon definition of bladder health and healthy bladder functions along with valid and
reliable measures of bladder health are necessary prerequisites.
The Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium was
established in 2015 with a mission to identify “bladder health” (BH) as a state to preserve
and protect; and to expand research in the area of clinical practice, and policies beyond the
detection and treatment of LUTS to the promotion and preservation of bladder health and
prevention of LUTS in women and in girls from school age through adolesence.16 The
PLUS Research Consortium is comprised of a transdisciplinary network of professionals,
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including community advocates, health care professionals with diverse clinical expertise,
and scientists representing over 20 disciplines. The details of the consortium’s history,
process and purpose have been previously reported.16
As no research definition for bladder health existed, the first step necessary for the
consortium to achieve its goals was to establish a research definition of bladder health (see
Lukacz et al. for a description of this process).17 Consistent with the World Health
Organization’s definition of health,18 the PLUS Research Consortium conceptualizes
bladder health as “a complete state of physical, mental and social well-being related to
bladder function, and not merely the absence of LUTS,” with function that “permits daily

Author Manuscript

activities, adapts to short term physical or environmental stressors, and allows optimal wellbeing (e.g., travel, exercise, social, occupational or other activities).17 This research
definition highlights individual function and subjective experiences associated with wellbeing. Consistent with the tenets of prevention science, the PLUS Research Consortium is
applying a life course developmental perspective to planned etiologic research.19 The
objective of this paper is to present the research definitions developed by the PLUS Research
Consortium for assessing the spectrum of bladder health, from bladder health to dysfunction
across the life course.

Materials and Methods

Author Manuscript

The process by which the PLUS Consortium developed a research definition of BH has been
previously reported.17 A subgroup of PLUS investigators that included research and clinical
experts convened into a Terminology and Conceptual Framework & Models (TCFM)
Intellectual Resource Group. After development of the bladder health definition, the fourteen
members of TCFM continued to develop and refine specific terminology and definitions for
the storage, emptying, and bioregulatory elements of healthy bladder function. Our initial
objective was to propose BH research definitions that could be developed, organized,
compared and displayed in a similar and parallel fashion to existing ICS defined LUTS.1–7

Author Manuscript

At the outset of this work, a broad search and review of the literature was conducted using
PubMed, Ovid Medline and Scopus for current bioregulatory, bladder health, and LUTS
terminology or definitions. The search also included the active or current ICS
Standardisation and Terminology Reports and Documents (https://www.ics.org/folder/92)
and confirmed an absence of published research definitions of bladder health or healthy
bladder functions.20 While “normative data” have been published for certain bladder
function measurements in women, the study populations are typically described as “normal”,
“healthy” or “asymptomatic”, all based on the absence of one or more LUTS symptoms.
21–23 However “normal” or “asymptomatic” function based solely on the absence of LUTS
may not necessarily equate to healthy function. Thus, the PLUS Research Consortium terms
and definitions were developed based on the recognized “two-phase” concept of bladder
function (Storage and Emptying) described by Wein et al.24 Published LUTS definitions
provided definable starting points for developing bladder health function definitions.1–7
Since the proposed BH definitions are for women and girls, the ICS/IUGA Joint Report on
the Terminology for Female Pelvic Floor Dysfunction and The Standardization of
Terminology of Lower Urinary Tract Function in Children and Adolescents: Report from the
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Standardisation Committee of the International Children’s Continence Society served as the
primary basis for the LUTS definitions.4,7
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The concept of “elements of function” was developed by the TCFM group during BH
definition creation to reflect key elements of each function. The elements of storage function
were determined to include “capacity” and “continence” during daytime (waking) and
nighttime (sleeping) periods; as well as “sensation” of urge and comfort during filling and
storage. Emptying functions of the bladder include “initiation,” “stream flow” (including
speed, character, and continuity), “efficacy” (completeness), and “sensation” (including
relief of urge, completeness, and comfort during and after voiding). The elements of storage
and emptying functions were compared with accepted definitions of LUTS obtained from
published terminology recommended by international organizations.1–7,20,25 For each
element of bladder function, a bladder health definition based on subjective experience was
proposed.
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The definitions of elements of bladder function corresponding to both BH and LUTS were
refined using an iterative process, balancing the needs to be descriptive, clinically relevant
and meaningful, while also easy to use and understandable by a lay population, clinicians,
and researchers. While the IUGA/ICS definitions for LUTS is the gold standard for current
terminology, in order to incorporate a more patient centered language throughout our work,
the PLUS consortium has made a few, minor modifications to this terminology.
Modifications to published LUTS definitions were suggested by the TCFM when it was
thought that a refinement in definition would increase specificity, clarity, or be more patientcentered. The TCFM elected to diverge from typical ICS phrasing of symptom definitions
which include the phrase “the complaint of…”. While the initial intent of this phrasing was
likely to clarify that a symptom is reported by the patient as bothersome, it was felt that use
of “complaint” could have a negative connotation. In contrast to LUTS definitions, priority
was given to defining BH using positive attributes. Thus, these definitions avoided double
negative language such as “denies complaint of…” and used positive phrasing such as “the
bladder empties completely with minimal effort” for Emptying – Efficacy.
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Finally, the novel concept of a bladder “bioregulatory” function was acknowledged,
recognizing that the bladder lining and urine composition may play a role in bladder health
and dysfunction.26 Definitions were proposed for a “Biosis barrier” describing the role of
the bladder microbiome in preventing infection, a “chemical or physical barrier” describing
the role of the urothelium in prevention of absorption of chemicals, and a “neoplastic
barrier” describing the regulated turnover of cells to maintain health and prevent malignancy.
Unlike the storage and emptying functions, which can be assessed subjectively, the
bioregulatory functions require objective assessment.
Based on the overarching research definition of BH developed by the PLUS Consortium,
definitions for elements of BH function were developed to include the perspective of aging
and chronic disease (where complete well-being may be unattainable and health is the ability
to adapt and self-manage) and allostasis (defined as resilience to short-term physical, social
and environmental stressors).17 Thus, the definitions of BH were developed and structured to
be compatible with existing ICS terminology, but also extend beyond ICS terminology with
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respect to their emphasis on health across the life course and allostasis in the context of
short-term stressors.
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An initial table was developed and structured by bladder function (Storage, Emptying,
Bioregulatory) and elements of function. The TCFM process of definition development
occurred iteratively over 14 months and included pre-meeting preparation and review of
circulated documents and current versions of existing and proposed BH and LUTS
definitions. Committee members provided comments and suggested edits that were routinely
collated and circulated to the group after TCFM leads noted specific issues or items to be
discussed during meetings. Discussions of definitions and related issues were conducted
until consensus was met. If committee members were not available for web-based or inperson meetings, they provided comments in advance of the meeting or upon review of an
updated draft circulated after the meeting. If a new publication including LUTS definitions
or terminology was identified in the literature between meetings, the document was
circulated to the group for review and the table was annotated with definition(s) for
discussion at the next meeting.

Author Manuscript

Terminology and definitions were circulated to the entire 83 member consortium for
comment prior to approval and adoption by the consortium. Agreement on research
definitions by the Consortium was reached by consensus. As over a year had passed since
initiation of this work, a broad literature search was conducted again in PubMed, Ovid
Medline and Scopus for current bioregulatory, bladder health or LUTS terminology or
definitions. The search also included the active or current ICS Standardisation And
Terminology Reports and Documents to ensure new or updated LUTS terminology was
included and to identify if any bioregulatory or BH terminology had been published in the
interim.20 Based on the initial terminology table, a comprehensive reference table of
research terminology and definitions was designed for use by the PLUS Research
Consortium for development of an instrument(s) to measure bladder health in women and
school age and adolescent girls.

Results

Author Manuscript

Proposed research definitions for subjective experiences of BH in women and girls across
the elements of bladder function, along with objective measures of bioregulatory function,
are presented in Table 1. These definitions include “overall” definitions of storage,
emptying, and bioregulatory functions and seven elements of storage-related definitions,
seven elements of emptying-related definitions, and three elements of bioregulatory-related
definitions. In accordance with recommendations in the review of terminology by ICS in
2004, “voiding” was used in place of micturition, passing urine or urination in both existing
ICS LUTS terminology and newly proposed BH and LUTS definitions.3 Existing ICS LUTS
definitions for elements of bladder function are listed along with the newly proposed BH and
LUTS definitions for comparison (definition listed with corresponding reference).1–7
Overall Definitions
Overall definitions for elements of bladder function were developed for LUTS and BH. The
overarching definition of BH served as the foundation for the sub-component BH definitions
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for Storage, Emptying and Bioregulatory. No “overall” definition for the subjective
experience of LUTS existed (noted as “new”); therefore definitions were proposed as
follows:

Author Manuscript

•

BH (Overall): A complete state of physical, mental and social well-being related
to bladder function, and not merely the absence of LUTS. Healthy bladder
function does not impact daily activities on a routine basis, is adaptable to short
term physical or environmental stressors, and allows pursuit of optimal wellbeing (e.g. travel, exercise, social, occupational or other activities).17

•

LUTS (Overall): The subjective indicator of bladder dysfunction or change in
bladder function as perceived by the patient, caregiver, or partner, which may
lead to seeking help from healthcare professionals. (PLUS modification)

•

Storage Function

•

Author Manuscript
Author Manuscript

•

–

BH Storage (Overall): Ability to hold urine for a reasonable duration of
time and sense bladder fullness without fear of or concern about
urgency, discomfort, or leakage. Storage function does not impact daily
activities on a routine basis, is adaptable to short term physical or
environmental stressors, and allows pursuit of optimal well-being (e.g.
travel, exercise, social, occupational or other activities).

–

LUTS Storage Symptoms (Overall): Bothersome LUTS that occur with
filling of the bladder with urine. (PLUS modification)

Emptying Function
–

BH Emptying (Overall): The ability to empty the bladder completely in
a timely, efficient, effortless, comfortable manner. Emptying function
does not impact daily activities on a routine basis, is adaptable to short
term physical or environmental stressors, and allows pursuit of optimal
well-being (e.g. travel, exercise, social, occupational or other activities).

–

LUTS Emptying Symptoms (Overall):
♦

Voiding symptoms: A departure from normal sensation or
function, experienced during or following the act of voiding.4
(PLUS modification)

♦

Bothersome LUTS that occur during or immediately following
bladder emptying of urine. (PLUS modification)

Bioregulatory Function
–

BH Bioregulatory Barrier Function (Overall): The bladder barrier
protects from pathogens, chemicals, and malignancy; is adaptable to
short term physical or environmental stressors; and is able to
completely recover from disruption of the barrier layer, without long
term or persistent sequelae.
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LUTS Bioregulatory Barrier Dysfunction (Overall): A disruption in
the protective barrier of the bladder resulting in LUTS. (PLUS
definition)

Elements of Storage Function Definitions
•

BH Capacity/Frequency – Day/Waking: A frequency of voiding during waking
hours that does not impact daily activities on a routine basis; and is adaptable to
short term physical or environmental stressors, and allows pursuit of optimal
well-being (e.g. travel, exercise, social, occupational or other activities).

•

LUTS Capacity/Frequency – Day/Waking:

Author Manuscript

–

Voiding frequency during waking hours that occurs more frequently
than desired and/or impacts daily activities on a routine basis. (PLUS
definition)

–

Increased daytime urinary frequency: Voiding occurs more
frequently during waking hours than deemed normal.2,4 (PLUS
modification)

•

BH Capacity/ Frequency – Night/Sleeping: A frequency of voiding during
sleeping hours, due tthe urge tvoid, that allows for optimal sleep quality and is
within physiologic age norms; and does not impact daily activities on a routine
basis, is adaptable tshort term physical or environmental stressors, and allows
pursuit of optimal well-being (e.g. travel, exercise, social, occupational or other
activities).

•

LUTS Capacity/Frequency – Night/Sleeping:

Author Manuscript

•

Author Manuscript

•

–

Voiding during sleeping hours occurs more frequently than desired and
impacts sleep quality and/or quantity. (PLUS definition)

–

Nocturia: Interruption of sleep one or more times because of the need
tvoid. Each void is preceded and followed by sleep.4 (PLUS
modification)

BH Continence - Day/Waking:
–

The ability thold urine during waking hours for a reasonable duration of
time and throughout daily activities without any leakage of urine.
Maintenance of continence does not impact daily activities on a routine
basis, is adaptable tshort term physical or environmental stressors, and
allows a woman tpursue her optimal well-being (e.g. travel, exercise,
social, occupational or other activities).

–

At completion of voiding there is continence (i.e. nsubsequent leakage
or dribbling of urine).

LUTS Continence - Day/Waking:
–

Urinary incontinence (UI): Involuntary loss of urine.2,4 (PLUS
modification)

Neurourol Urodyn. Author manuscript; available in PMC 2020 June 01.

Lowder et al.

Page 9

–

Author Manuscript
Author Manuscript

–

•

Author Manuscript

•

Types of UI (PLUS modification):4
♦

Stress UI: urine loss with physical exertion, sneezing, or
coughing

♦

Urgency UI: urine loss associated with urgency

♦

Postural UI: urine loss with change in body position

♦

Mixed UI: urine loss with urgency and alswith physical
exertion, sneezing, or coughing OR urgency and stress UI

♦

Continuous UI: continuous urine loss

♦

Insensible UI: urine loss without awareness

♦

Coital UI: urine loss with coitus

Post void dribble (post void leakage): Involuntary passage of urine
following the completion of voiding.4 (PLUS modification)

BH Continence - Night/Sleeping:
–

The ability thold urine during sleeping hours, without leakage of urine.
Maintenance of continence does not impact her own, her partner’s or
caregiver’s sleep or daily activities on a routine basis, is adaptable
tshort term physical or environmental stressors, and allows a woman
tpursue her optimal well-being (e.g. travel, exercise, social,
occupational or other activities).

–

At completion of voiding during sleeping hours there is continence (i.e.
nsubsequent leakage or dribbling of urine).

LUTS Continence - Night/Sleeping:
–

Nocturnal enuresis: Involuntary loss of urine that occurs during sleep
and is recognized after awakening.2,4 (PLUS modification)

–

Nocturnal urgency incontinence: Leakage of urine on the way tthe
toilet upon waking from sleep due turgency tvoid. (PLUS definition)

–

Nocturnal post void dribble (post void leakage): Involuntary passage
of urine following the completion of voiding during sleeping hours.4
(PLUS modification)

Author Manuscript

•

BH Sensation – Urge: The awareness and sensation of urge and bladder fullness
that allows sufficient time tget tthe toilet without fear of leakage; and does not
impact daily activities on a routine basis, is adaptable tshort term physical or
environmental stressors, and allows pursuit of optimal well-being (e.g. travel,
exercise, social, occupational or other activities).

•

LUTS Sensation – Urge:
–

Urinary urgency: The sudden, compelling desire tpass urine that is
difficult tdefer.4 The urgency may be associated with fear of urine loss
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before making it tthe toilet. Despite absence of leakage, this may cause
distress or bother, and/or impact daily activities. (PLUS modification)
–

Absence of urge: The lack of sensation at full capacity. (PLUS
definition)

•

BH Sensation – Comfort: The bladder fills and stores urine with increasing
degree of sensation; and does not impact daily activities on a routine basis, is
adaptable tshort term physical or environmental stressors, and allows pursuit of
optimal well-being (e.g. travel, exercise, social, occupational or other activities).

•

LUTS Sensation – (Dis)Comfort:
–

Author Manuscript

Bladder pain: Suprapubic or retropubic pain, pressure, or discomfort
related tthe bladder, and usually increasing in degree of sensation with
bladder filling. Sensation may persist or be relieved after voiding.2,4

Elements of Emptying Function Definitions
•

BH Voiding Initiation: Voiding proceeds when intended and without effort; and
does not impact daily activities on a routine basis, is adaptable tshort term
physical or environmental stressors, and allows pursuit of optimal well-being
(e.g. travel, exercise, social, occupational or other activities).

•

LUTS Voiding Initiation:
–

Hesitancy: A delay in initiating voiding.4 (PLUS modification)

Author Manuscript

•

BH Stream Flow – Speed: Voiding occurs in an amount of time that does not
impact daily activities on a routine basis, is adaptable tshort term physical or
environmental stressors, and allows pursuit of optimal well-being (e.g. travel,
exercise, social, occupational or other activities).

•

LUTS Stream Flow – Speed:
–

Slow stream: The urinary stream is perceived as slower compared
tprevious performance or in comparison with others.4 (PLUS
modification)

Author Manuscript

•

BH Stream Flow – Character: Voiding occurs in a uniform stream without
spraying or splitting; and does not impact daily activities on a routine basis, is
adaptable tshort term physical or environmental stressors, and allows pursuit of
optimal well-being (e.g. travel, exercise, social, occupational or other activities).

•

LUTS Stream Flow – Character:
–

•

Spraying (splitting) of urinary stream: Urine is passed as a spray or
split rather than a single discrete stream.4 (PLUS modification)

BH Stream Flow – Continuity: Voiding occurs continuously without
interruption and does not impact daily activities on a routine basis, is adaptable
tshort term physical or environmental stressors, and allows pursuit of optimal
well-being (e.g. travel, exercise, social, occupational or other activities).
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LUTS Stream Flow – Continuity:
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–

Intermittency: Urine flow that stops and starts on one or more
occasion during voiding.4

•

BH Efficacy: The bladder empties completely with minimal effort; and does not
impact daily activities on a routine basis, is adaptable tshort term physical or
environmental stressors, and allows pursuit of optimal well-being (e.g. travel,
exercise, social, occupational or other activities).

•

LUTS Efficacy:
–

Urinary retention: The inability tvoid completely despite persistent
effort in the presence of a full bladder.4 (PLUS modification)

Author Manuscript

•

BH Sensation – Urge relief: The bladder feels empty and without urinary urge
or urgency after voiding; and does not impact daily activities on a routine basis,
is adaptable tshort term physical or environmental stressors, and allows pursuit of
optimal well-being (e.g. travel, exercise, social, occupational or other activities).

•

LUTS Sensation – Urge
–

Persistent urgency: Sensation of urinary urge or urgency after voiding.
(PLUS definition)

–

Need timmediately re-void: Sensation that further voiding is necessary
soon after passing urine. (PLUS modification)

Author Manuscript

•

BH Sensation – Completeness: The bladder feels empty at the end of voiding;
and does not impact daily activities on a routine basis, is adaptable tshort term
physical or environmental stressors, and allows pursuit of optimal well-being
(e.g. travel, exercise, social, occupational or other activities).

•

LUTS Sensation – Completeness
–

Feeling of incomplete (bladder) emptying: Sensation that the bladder
is not empty after voiding.4 (PLUS modification)

–

Non-neurogenic chronic urinary retention: An elevated post-void
residual of greater than 300 mL that persists for at least 6 months and is
documented on twor more separate occasions.25

–

Post void dribble (post void leakage): Involuntary passage of urine
following the completion of voiding.4 (PLUS modification)

Author Manuscript

•

BH Sensation – Comfort: The bladder empties with decreasing degree of
sensation; and does not impact daily activities on a routine basis, is adaptable
tshort term physical or environmental stressors, and allows pursuit of optimal
well-being (e.g. travel, exercise, social, occupational or other activities).

•

LUTS Sensation – (Dis)comfort:
–

Dysuria: Urethral pain, burning or other discomfort during voiding.4
(PLUS modification)
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•

BH Biosis Barrier: A healthy relationship (symbiosis) between host and bladder
microbiota that is adaptable tshort term physical or environmental stressors and
is able tcompletely recover from disruption of the microbiome and barrier layer,
without long term or persistent sequelae. (PLUS definition)

•

LUTS Biosis Barrier - Dysbiosis and/or infection: Disruption of the symbiotic
relationship between host and healthy bladder microbiota. (PLUS definition)

•

BH Physical/Chemical Barrier: The intact urothelium that lines the bladder
(basal/intermediate/umbrella cells) provides a barrier between irritating urinary
substances and underlying neuromuscular tissue; is adaptable tshort term
physical or environmental stressors; and is able tcompletely recover from
disruption of the microbiome and barrier layer, without long term or persistent
sequelae. (PLUS definition)

•

LUTS Physical/Chemical Barrier: A breakdown in the apical layer of
urothelium (‘umbrella cells’) due tdisruption of tight-junction complexes and
uroplakins (hexagonal plaques) and/or the sulfated polysaccharide
glycosaminoglycan (GAG) layer, allowing passage of toxic and irritating urinary
substances through the urothelium or release of neuroactive chemicals
stimulating LUTS. (PLUS definition)

•

BH Neoplastic Barrier: The intact urothelium that lines the bladder (basal/
intermediate/umbrella cells) sloughs and regenerates in a regulated manner; and
is adaptable tshort term physical or environmental stressors; and is able
tcompletely recover from disruption of the microbiome and barrier layer, without
long term or persistent sequelae.

•

LUTS Neoplastic Barrier: Malignancy that forms in tissues of the bladder. Most
bladder cancers are transitional cell carcinomas. Other types include squamous
cell carcinoma and adenocarcinoma. (PLUS definition)

Discussion

Author Manuscript

Bladder function has been primarily defined through the presence or absence of LUTS and
functional urodynamic studies. The reliance on urodynamic studies tobjectively assess
bladder function arose from clinician dissatisfaction with reliance on reported LUTS
symptoms alone.27 Current standardized terminology tdescribe the lower urinary tract has
allowed researchers and clinicians tcommunicate in meaningful ways; however, the current
terminology describes bladder dysfunction rather than bladder health.1–7 Until now there has
been little need for terminology about the opposite end of the spectrum tfacilitate research
that informs practice, with the goal of bladder health promotion and LUTS prevention. In
this manuscript, we present our transdisciplinary research consortium’s proposed
terminology for bladder health functions using the International Continence Society’s
standardization publications of Lower Urinary Tract Function as a framework.1–7 The intent
of this effort is tpropose research definitions for bladder function from the perspective of
health, which will be used for research instrument development within the PLUS Research
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Consortium. We dnot intend for these tbe clinical terms until further research supports these
definitions. We recognize that, whenever possible, the ICS and IUGA use an evidence-based
approach that incorporates a transdisciplinary perspective for developing terminology
documents. When supported by evidence, organizations such as ICS and IUGA may wish
tconsider adopting and/or adapting some of this proposed terminology in the future.
Currently these are for research purposes only and PLUS hopes other researchers can benefit
from this transdisciplinary team science work product and approach. We hope this work will
spur global exploration of the promotion of bladder health and prevention of LUTS. We
anticipate that the language of researchers will need further refinement, informed by use of
the terminology and definitions and future research including community engagement. The
ultimate goal is for the proposed research definitions tmeet the needs of the stakeholders:
women and girls, clinicians, public health practitioners and policy makers.

Author Manuscript
Author Manuscript

While large investments have been made in the prevention of other prevalent conditions such
as obesity and cardiovascular disease8,28,29, investment in bladder health and the prevention
of LUTS is comparatively small. One reason for this disparity may be that medical
specialists in lower urinary tract dysfunction traditionally considered the absence of disease
tbe synonymous with bladder health. We posit that clear definitions of both health and
disease states are critical tconducting research that will aid in understanding and promoting
bladder health. Bladder dysfunction is well represented in the research literature and clinical
practice by the dissemination and use of LUTS definitions. In this manuscript, we offer
research definitions that correspond twidely recognized bladder functions of storage and
emptying; in addition, we propose definitions for more recently recognized aspects of
bladder function, which we collectively refer tas the bioregulatory function. This
bioregulatory definition is not intended trepresent an exhaustive or comprehensive list of all
the biologic functions of the bladder, but rather thighlight the importance of bioregulatory
function and acknowledge the role of the urothelium and microbiome in bladder health.26

Author Manuscript

With the introduction of new research terminology, feedback from users will be critical.
Homma noted that as LUTS terminology was used, confusion developed among researchers
and clinicians when the terms were used as both symptoms and cystometric terms.30 Clearly,
the transdisciplinary science of bladder health is in its nascent stages and the terminology
presented in this paper should be viewed as a starting point tcreate a common language with
the intent trevise it as knowledge advances. In addition, as others have found, lay persons
use different terms and descriptions of function and symptoms than healthcare providers.31
A balance may need tbe struck between pragmatism, terms people can readily identify with,
and professional consensus on the usefulness of the terminology in conducting and
interpreting research.32 We recognize that validation of the language used in the subjective
and objective experiences of women and girls by end-users (i.e. women and girls,
researchers and clinicians) is critical.
The main strength of this bladder health research terminology framework is that a
transdisciplinary group comprised of clinical, health behavior, and research methods experts,
in an iterative process, created the proposed definitions. Bladder health research definitions
correspond twidely recognized bladder functions of storage and emptying and LUTS
symptoms; they additionally correspond tmore recently recognized aspects of bladder
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function, which we collectively refer tas bioregulatory function. The literature was reviewed
for existing LUTS and bladder health terminology, existing definitions were modified where
deemed appropriate, and only in situations where nexisting terminology existed, new
definitions were created. 1–7,17

Author Manuscript

The limitations tthis approach include the fact that these definitions were developed by a
single group from a single country using English Language, and these definitions may not be
applicable tclinical or community practice. However, our method is consistent with those
described by other organizations developing and standardizing terminology for LUTS.
1–7,20,33 In addition, our interpretation of some bladder function elements, such as “post void
dribble,” differs from current description of the “two-phase” concept of bladder function.24
Our transdisciplinary group struggled with whether this symptom represents a failure of the
emptying or storage bladder function and decided tinclude a description under both, as
women and girls may identify post void dribble with different functions. Further research in
this area is needed tdetermine if our interpretation is supported. Also, some of the
components of the definitions we have developed, such as the urinary microbiome or what
defines a “short term” stressor, are not yet fully understood. We hope that this work may
serve as a foundation upon which bladder health terminology can continue tevolve. Ongoing
review, refinement, and definition development by our group and others is not only
anticipated, but essential twidespread acceptance and use.

Author Manuscript

With research definitions of both bladder health and dysfunction, scientists of diverse
disciplines will be positioned tconduct rigorous prevention science work. Etiologic studies
are needed tidentify risk and protective factors for optimal bladder function across different
levels of biology (e.g., cellular function, organ systems) and the social ecology that
surrounds individuals (e.g., toileting environments and norms). With results from etiologic
research, scientists will be positioned tdevelop and test prevention interventions aimed at
modifying risk and protective factors, with the goals of promoting bladder health, preventing
LUTS, and moderating major dysfunction due tLUTS.

Conclusions

Author Manuscript

The bladder health research terminology and definitions presented represent a
transdisciplinary approach tstandardizing definitions for different elements of bladder
function from a perspective of bladder health. The proposed PLUS bladder health and
dysfunction terminology in this paper are for research purposes in the PLUS consortium’s
work tbetter understand bladder health. This work provides a framework of bladder function
and definitions of BH for research, which may in turn inform clinical practice, public health
promotion and LUTS prevention. We dnot expect that these research definitions will be
embraced by all members of the medical and scientific community; however, these are the
definitions the PLUS Research Consortium is using tfurther our BH promotion and LUTS
prevention research agenda. These definitions are currently being used tdevelop novel
instruments tmeasure BH across a broad socio-demographic spectrum of women and girls.
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A frequency of voiding during sleeping hours, due
turge tvoid, that allows for optimal sleep quality and is
within physiologic age norms*

a. Voiding frequency during sleeping hours that occurs more frequently than desired
and impacts sleep quality and/or quantity. (PLUS definition)
b. Nocturia: Interruption of sleep one or more times because of the need tvoid. Each
void is preceded and followed by sleep. †
a. Urinary incontinence: Involuntary loss of urine. †
b. Types of UI† :
• Stress UI: urine loss with physical exertion, sneezing, or coughing
• Urgency UI: urine loss associated with urgency
• Postural UI: urine loss with change in body position
• Mixed UI: urine loss with urgency and alswith physical exertion, sneezing, or
coughing OR urgency and stress UI
• Continuous UI: continuous urine loss
• Insensible UI: urine loss without awareness
• Coital UI: urine loss with coitus
c. Post void dribble (post void leakage): Involuntary passage of urine following the
completion of voiding. †
a. Nocturnal enuresis: Involuntary loss of urine that occurs during sleep and is
recognized upon awakening. †
b. Nocturnal urgency incontinence: Leakage of urine on the way tthe toilet upon
waking from sleep due turgency tvoid. (PLUS definition)
c. Nocturnal post void dribble (post void leakage): Involuntary passage of urine
following the completion of voiding during sleeping hours. †
a. Urinary urgency: The sudden, compelling desire tpass urine that is difficult
tdefer. The urgency may be associated with fear of urine loss before making it tthe
toilet. Despite absence of leakage, this may cause distress or bother, and/or impact
daily activities. †
b. Absence of urge: The lack of sensation at full capacity. (PLUS definition)

Capacity/ Frequency – Night/
Sleeping

Continence -Day/Waking

Continence -Night/Sleeping

Neurourol Urodyn. Author manuscript; available in PMC 2020 June 01.
Sensation - Urge

The awareness and sensation of urge and bladder
fullness that allows sufficient time tget tthe toilet
facilities without fear of leakage*

a. The ability thold urine during sleeping hours,
without leakage of urine*
b. At completion of voiding during sleeping hours
there is continence (i.e. nsubsequent leakage or
dribbling of urine) *

a. The ability thold urine during waking hours for a
reasonable duration of time and throughout daily
activities without any leakage of urine*
b. At completion of voiding there is continence (i.e.
nsubsequent leakage or dribbling of urine) *

A frequency of voiding during waking hours that does
not impact daily activities on a routine basis*.

a. Voiding frequency during waking hours that occurs more frequently than desired
and/or impacts daily activities on a routine basis. (PLUS definition)
b. Increased daytime urinary frequency: Voiding occurs more frequently during
waking hours than previously deemed normal. †

Subjective Experience(s)

Capacity/ Frequency – Day/
Waking

LUTS/Subjective Experience(s)

Ability thold urine for a reasonable duration of time
and sense bladder fullness without fear of or concern
about urgency, discomfort or leakage*

Overall

Storage

A complete state of physical, mental and social wellbeing related tbladder function, and not merely the
absence of LUTS. Healthy bladder function does not
impact daily activities on a routine basis, is adaptable
tshort term physical or environmental stressors, and
allows pursuit of optimal well-being (e.g. travel,
exercise, social, occupational or other activities)*.

Bladder Health (BH)
(PLUS definitions)

Bothersome LUTS that occur with filling of the bladder with urine. †

Elements of Function

Bladder Function

The subjective indicator of a disease or change in condition as perceived by the
patient, caregiver, or partner and may lead her tseek help from healthcare
professionals. (PLUS modification†)

Bladder Dysfunction

Detailed bladder dysfunction and health table addressing functions as well as symptoms and experiences of the bladder in health and disease.
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Barrier Function

Biregulatory

Overall

LUTS Subjective Experience(s)

Urinary retention: The inability tvoid completely despite persistent effort in the
presence of a full bladder. †
a. Persistent urgency: Sensation of urinary urge or urgency after voiding. (PLUS
definition)
b. Need timmediately re-void: Sensation that further voiding is necessary soon
after passing urine. †
a. Feeling of incomplete (bladder) emptying: Sensation that the bladder is not
empty after voiding. †
b. Non-neurogenic chronic urinary retention: An elevated post-void residual of
greater than 300 mL that persists for at least 6 months and is documented on twor
more separate occasions.25
c. Post void dribble (post void leakage): Involuntary passage of urine following the
completion of voiding. †

Efficacy
Sensation – Urge relief

Sensation - Completeness

LUTS Objective Experience(s)

Bladder Health Objective Experience(s)

A healthy relationship (symbiosis) between host and
bladder microbiota**
The intact urothelium that lines the bladder (basal/
intermediate/umbrella cells) provides a barrier between

A breakdown in the apical layer of urothelium (‘umbrella cells’) due tdisruption of
tight-junction complexes and uroplakins (hexagonal plaques) and/or the sulfated
polysaccharide glycosaminoglycan (GAG) layer allowing passage of toxic and

Physical/ Chemical Barrier

The bladder barrier protects the individual/host from
pathogens, chemicals, and malignancy; is adaptable
tshort term physical or environmental stressors and is
able tcompletely recover from disruption of the barrier
layer, without long term or persistent sequelae.

Dysbiosis and/or infection: Disruption of the symbiotic relationship between host
and healthy bladder microbiota. (PLUS definition)

A disruption in the protective barrier of the bladder resulting in LUTS. (PLUS
definition)

The bladder empties with decreasing degree of
sensation*

The bladder feels empty at the end of voiding*

The bladder feels empty without urinary urge or
urgency after voiding*

The bladder empties completely with minimal effort*

Voiding occurs continuously without interruption*

Voiding occurs in a uniform stream without spraying
or splitting*

Voiding occurs in an amount of time that does not
impact daily activities*

Voiding proceeds when intended and without effort*

The ability tempty the bladder completely in a timely,
efficient, effortless, comfortable manner*

Subjective Experience(s)

The bladder fills and stores urine with increasing
degree of sensation*

Biosis barrier

Overall

Elements of Function

a. Dysuria: Urethral pain, burning, or other discomfort during voiding. †

Intermittency: Urine flow that stops and starts on one or more occasions during
voiding. †

Stream Flow - Continuity

Sensation -Comfort

Spraying (splitting) of urinary stream: Urine is passed as a spray or split rather
than a single discrete stream. †

Slow stream: The urinary stream is perceived as slower compared tprevious
performance or in comparison with others. †

Hesitancy: A delay in initiating voiding. †

a. Voiding symptoms: A departure from normal sensation or function, experienced
by the woman during or following the act of voiding. †
b. Bothersome LUTS that occur during or immediately following bladder emptying
of urine. †

Stream Flow - Character

Stream Flow - Speed

Voiding Initiation

Elements of Function

Author Manuscript

Emptying

Bladder pain: Suprapubic or retropubic pain, pressure, or discomfort, related tthe
bladder, and usually increasing with bladder filling. Sensation may persist or be
relieved after voiding. †
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Bladder Function
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Sensation - Comfort

Bladder Health (BH)
(PLUS definitions)
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Bladder Dysfunction
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The intact urothelium that lines the bladder (basal/
intermediate/umbrella cells) which sloughs and
regenerates in a regulated manner**

Malignancy that forms in tissues of the bladder. Most bladder cancers are
transitional cell carcinomas. Other types include squamous cell carcinoma and
adenocarcinoma. (PLUS definition)

in 2004, “voiding” was used in place of micturition, passing urine or urination in both existing ICS LUTS terminology and newly proposed BH and LUTS definitions.3 Definitions with this terminology
change are included with other “PLUS modifications” marked with a (†) symbol.

Each BH element of function definition for Storage and Emptying is followed with an asterisk (*) that refers tthe qualifying statement: “…and does not impact daily activities on a routine basis, is
adaptable tshort term physical or environmental stressors, and allows a woman tpursue her optimal well-being (e.g. travel, exercise, social, occupational or other activities).” For the Bioregulatory
BH elements of function definitions, each is followed by double asterisks (**) that refers tthe qualifying statement: “…and is adaptable tshort term physical or environmental stressors and is able
tcompletely recover from disruption of the microbiome and barrier layer, without long term or persistent sequelae.” In accordance with the recommendations in the review of terminology by the ICS

irritating urinary substances and underlying
neuromuscular tissue**

Author Manuscript
Neoplastic barrier

Author Manuscript

irritating urinary substances through the urothelium or release of neuroactive
chemicals stimulating LUTS. (PLUS definition)
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